tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP
US Market

GT Biopharma (GTBP) Financial Statements

Compare
227 Followers

GT Biopharma Financial Overview

GT Biopharma's market cap is currently $5.41M. The company's EPS TTM is $-7.48; its P/E ratio is ―; GT Biopharma is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -4.00K
Operating Income$ -13.58M$ -21.26M$ -57.52M$ -6.76M$ -16.06M
EBITDA$ 5.98M$ 0.00$ 0.00$ -24.98M$ -11.45M
Net Income$ -7.60M$ -20.50M$ -58.69M$ -31.62M$ -40.77M
Balance Sheet
Cash & Short-Term Investments$ 13.97M$ 16.51M$ 31.98M$ 5.30M$ 28.00K
Total Assets$ 14.11M$ 16.74M$ 32.17M$ 5.66M$ 396.00K
Total Debt$ 58.00K$ 174.00K$ 31.00K$ 26.33M$ 13.36M
Net Debt$ -1.02M$ -5.50M$ -8.94M$ 21.04M$ 13.33M
Total Liabilities$ 6.63M$ 5.00M$ 10.26M$ 35.09M$ 19.71M
Stockholders' Equity$ 7.48M$ 11.73M$ 21.91M$ -29.26M$ -19.14M
Cash Flow
Free Cash Flow$ -8.85M$ -15.22M$ -15.61M$ -7.26M$ -3.66M
Operating Cash Flow$ -8.85M$ -15.22M$ -15.61M$ -7.26M$ -3.66M
Investing Cash Flow$ -2.01M$ 12.14M$ -23.04M$ 0.00$ 200.00K
Financing Cash Flow$ 6.27M$ -224.00K$ 42.32M$ 12.53M$ 3.43M
Currency in USD

GT Biopharma Earnings and Revenue History

GT Biopharma Debt to Assets

GT Biopharma Cash Flow

GT Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis